Neuropsychopharmacology
- Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial1 year ago
- Heritable consequences of paternal heroin use: a role for miR-19b in drug-taking behavior1 year ago
- Correction: Lateral habenula induces cognitive and affective dysfunctions in mice with neuropathic pain via an indirect pathway to the ventral tegmental area1 year ago
- Random forest and Shapley Additive exPlanations predict oxytocin targeted effects on brain functional networks involved in salience and sensorimotor processing, in a randomized clinical trial in autism1 year ago
- Neighborhood social fragmentation in relation to impaired mismatch negativity among youth at clinical high risk for psychosis and healthy comparisons1 year ago
- Abnormal ventromedial-to-dorsolateral hierarchical topography of striatal circuits in cocaine use disorder and its modulations by brain stimulation1 year ago
- Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing1 year ago
Journal of Psychopharmacology
- The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study2 years ago
- Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins2 years ago
- Neural correlates of episodic memory decline following electroconvulsive therapy: An exploratory functional magnetic resonance imaging study2 years ago
- Cilia loss on distinct neuron populations differentially alters cocaine-induced locomotion and reward2 years ago
- Arbitration between model-free and model-based control is not affected by transient changes in tonic serotonin levels2 years ago
- Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom2 years ago
- Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults2 years ago
European Neuropsychopharmacology
- Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials2 years ago
- What is really different about older age bipolar disorder?2 years ago
- Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls2 years ago
- Impact of genetic, sociodemographic, and clinical features on antidepressant treatment trajectories in the perinatal period2 years ago
- Suicidal behavior: Not just an epiphenomenon of psychiatric illness2 years ago
- Social cognition in maltreated individuals: Do type and timing of maltreatment matter?2 years ago
- Using digital phenotyping to classify bipolar disorder and unipolar disorder – exploratory findings using machine learning models2 years ago